Microbiota in Dietary Approach to Obesity
Ketone Bodies and Gut Microbiota Role in the Dietetic Approach of Obesity
1 other identifier
interventional
150
1 country
1
Brief Summary
Main aim: Study the anthropometric, metabolic, cardiovascular and neurocognitive and gut microbiota changes of different approaches for the weight reduction that increase the ketone bodies in a different proportion in relation to the classic hypocaloric diet. Objective 1: Study the effect of hypocaloric diets that increase the ketone bodies on gut microbiota and its relationship with anthropometric changes and of the Brown adipose tissue, Objective 2: with the metabolic and inflammatory changes, Objective 3: on the cardiovascular system, Objective 4: on the neurocognition, Objective 5: if they are associated to epigenetic changes that may explain the changes found in the other objectives. Objective 6: Determine the safety of the diets that increase the ketone bodies compared to the classic hypocaloric diet, Objective 7: if the effects of the different dietary approaches are maintained during the medium time, and Objective 8: Verify in experimental models (microbiota transplants from humans with different diets to germ-free mice, ketosis dietary models, and ketone bodies administration) the causality of the gut microbiota of these findings. Methodology: Model 1: Dietary intervention in humans with 4 types of diet with a different increase of the ketone bodies: classic hypocaloric diet (DH); diet with 8h of feeding and 16h of starving in periods of 24h (D16); diet with intermittent caloric restriction (DA); and normal in protein and low in carbohydrates hypocaloric ketogenic diet (DC).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Jan 2020
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2020
CompletedFirst Submitted
Initial submission to the registry
April 17, 2020
CompletedFirst Posted
Study publicly available on registry
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 22, 2022
CompletedJuly 6, 2022
July 1, 2021
2.4 years
April 17, 2020
July 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in gut microbiota composition
To evaluate changes in gut microbiota composition from baseline using different strategies for weight loss which increase ketone bodies in comparison to a standard hypocaloric diet. Change from baseline in 16S rRNA amplicons of fecal community DNA at 3 months and 6 months
Baseline, 12 weeks
Secondary Outcomes (10)
Changes in weight
Baseline, 12 weeks
Changes in body mass index.
Baseline, 12 weeks
Changes in waist circumference.
Baseline, 12 weeks
Changes in body composition.
Baseline, 12 weeks
Changes in brown adipose tissue.
Baseline, 12 weeks
- +5 more secondary outcomes
Study Arms (5)
Standard hypocaloric diet
EXPERIMENTALMediterranean diet based on olive oil as main fat and regular consumption of vegetables (2 daily rations), fruits 3 daily rations), legumes (3 weekly rations), fish (3 weekly rations), with low consumption of red meat and meat products (less than twice a week), dairy foods (less than once a week) and no sweets, pastries or sugary drinks. Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein distributed in at least 4 meals (breakfast, lunch, afternoon snack and dinner).
Intermittent fasting 16/8 (early fasting)
EXPERIMENTALDiet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein, but it will be consumed for 8 hours a day (from 12 am. to 8 pm.), maintaining 16 fasting hours (from 8 pm. to 12 am. the following day).
Intermittent fasting 16/8 (late fasting)
EXPERIMENTALDiet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein, but it will be consumed for 8 hours a day (from 8 am. to 4 pm.), maintaining 16 fasting hours (from 4 pm. to 8 am. the following day).
Alternate-day fasting
EXPERIMENTALIn this diet subjects alternate norm caloric diet during 24 h (according to Harris-Benedict equation) and a diet including only 25% of caloric requirements the following 24 h (this day diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein).
Ketogenic diet
EXPERIMENTALDiet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein.
Interventions
Intermittent fasting 16/8 (early fasting)
Intermittent fasting 16/8 (late fasting)
Eligibility Criteria
You may qualify if:
- Obesity (BMI≥30-45 kg/m2)
You may not qualify if:
- Type 2 diabetes mellitus
- Patients with major cardiovascular events in the 6 months prior to the study beginning.
- Previous or current history of inflammatory disease.
- Active infectious disease.
- The refusal of the patient to participate in the study
- Consumption of probiotics or prebiotics
- Antibiotic therapy in the 3 months prior to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virgen de la Victoria Hospital
Málaga, 29010, Spain
Related Publications (2)
Martinez-Montoro JI, Bandera B, Gutierrez-Bedmar M, Gomez-Perez AM, Macias-Gonzalez M, Moreno-Indias I, Tinahones FJ. Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on weight loss in adults with obesity: a randomized clinical trial. BMC Med. 2025 Jul 1;23(1):368. doi: 10.1186/s12916-025-04182-z.
PMID: 40598397DERIVEDMela V, Heras V, Iesmantaite M, Garcia-Martin ML, Bernal M, Posligua-Garcia JD, Subiri-Verdugo A, Martinez-Montoro JI, Gomez-Perez AM, Bandera B, Moreno-Indias I, Tinahones FJ. Microbiota fasting-related changes ameliorate cognitive decline in obesity and boost ex vivo microglial function through the gut-brain axis. Gut. 2025 Oct 8;74(11):1828-1846. doi: 10.1136/gutjnl-2025-335353.
PMID: 40335161DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francisco J. Tinahones, PhD
Instituto de Investigacion Biomedica de Malaga
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2020
First Posted
July 1, 2020
Study Start
January 22, 2020
Primary Completion
June 9, 2022
Study Completion
June 22, 2022
Last Updated
July 6, 2022
Record last verified: 2021-07